Frontloading vs slow-titration — where my thinking has moved
23 posts
For about two years I was a die-hard frontloader. The argument: steady-state is the target, titration wastes weeks, and if you're going to have side effects they'll show up either way so you might as well see them fast.
I was wrong, or at least partially wrong. Here's why.
The frontload argument assumes side effects are either present or absent — a binary. In practice, most AEs are dose-dependent with a threshold, and that threshold is individual. Slow titration lets you find your threshold before stacking up metabolite load. A frontloader either walks past their threshold and stops (losing the cycle) or gets lucky and doesn't.
For compounds with a long tail (semaglutide's 7-day t1/2, CJC-DAC's week-long action) frontloading makes even less sense. Your 'loading dose' is a tissue dose you'll eat for weeks.
Short half-life peptides (Ipa, hexarelin, BPC) — frontload argument has more merit because the half-life is short enough that you can adjust in days, not weeks. Even then the upside is marginal.
My current default: titrate on anything with a half-life > 24hr, start-dose on short half-lifes. Thoughts?
16 Replies
25 posts
Appreciate this post. I've been on the titration side for years and the half-life heuristic you landed on is exactly right. It's not titration vs frontload as ideologies, it's half-life-matched ramp speed as a protocol principle.
94 posts
Good update. I'd add: for anything with receptor desensitization risk, slow-titrate is structurally better even for short half-life compounds because you extend the useful life of the cycle. Ipa at 100/150/200 over 3 weeks will give you more weeks of response than starting at 200.
- CJC-1295 no DAC · 100 mcg · pre-bed · sub-Q
- Ipamorelin · 200 mcg · pre-bed · sub-Q
- BPC-157 · 250 mcg · 2x/day · sub-Q
41 posts
Big agree on the long-tail point. Frontloading sema is how people end up with weeks of unremitting nausea. The compound can't be 'backed off' quickly because the tissue level decays on its own clock.
10 posts
Disagree on one point — for BPC-157 the short half-life would suggest frontload is fine, but in my experience the 'healing effect' has a threshold that takes 5-7 days of consistent dosing to kick in regardless of dose size. So frontloading BPC doesn't meaningfully accelerate onset. Slow-start works just as well.
16 posts
The corollary that should be said more often: the same half-life logic applies to taper. Short half-life, abrupt stop is fine. Long half-life, plan your off-ramp or you'll have weeks of declining dose that you didn't choose.
39 posts
@protocolwonk it's graded but saturable. The pulse size scales with dose up to roughly 100-150mcg per pulse, then plateau. Going higher doesn't give bigger pulse, it just extends the window slightly. Which means starting at 100 vs titrating from 50 is a minor difference for most people.
46 posts
Question — for GHRH analogs (CJC no-DAC, mod-GRF), is the pituitary response graded or threshold-based? I've heard both.
205 posts
@loading_phase that matches my clinical sense of BPC. The systemic effect has a lag independent of plasma level. Tissue uptake and signaling cascade take a few days to build.
- CJC-1295 no DAC · 100 mcg · pre-bed · sub-Q
- Ipamorelin · 200 mcg · pre-bed · sub-Q
- BPC-157 · 500 mcg · 2x/day · sub-Q
23 posts
@dr_doubt that's a point I hadn't articulated but agree with. Titration is a form of body-awareness training. You learn your thresholds and you carry that knowledge forward.
115 posts
71 posts
There's a 2019 review on GLP-1 titration that argues slow ramping reduces discontinuation rates by ~40% vs rapid. Not peptide-specific but the principle translates. Slow wins on adherence.
12 posts
For anyone landing here and thinking 'so I should always titrate' — note the exception class is real. Short-half-life peptides with no desensitization and no side effect threshold issues can absolutely be started at target dose. BPC as frontloader-lite was a sensible practice. The nuance matters.
- IGF-1 LR3 · 30 mcg · post-workout · sub-Q
- CJC-1295 no DAC · 100 mcg · pre-bed · sub-Q
- Ipamorelin · 200 mcg · pre-bed · sub-Q
- MGF (PEG) · 200 mcg · post-workout · sub-Q
23 posts
@the_architect_p I'm updating my priors publicly. It's a feature of the forum, not a bug.
9 posts
Reading frontloader concede ground is a Tuesday morning treat. Saving this thread.
71 posts
This is the kind of post that justifies having a forum at all. Solid.
- BPC-157 · 500 mcg · 2x/day · sub-Q
- GHK-Cu · 2 mg · nightly topical · topical